Richard S. Finn, MD: The Combination Of PD 0332991 and Letrozole Phase II Results

Dr. Richard S. Finn sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss  the combination of PD 0332991 and letrozole phase II clinical trial results.

Richard S. Finn, MD is Associate Professor at the Jonsson Comprehensive Cancer Center at UCLA.

Advocacy and educational support provided in part by:

Eisai Lilly Logos SABCS 2012

Comments